In this in vitro study, we investigated potential protective effects of hexarelin and JMV2894 on human neuroblastoma cells overexpressing the SOD1-G93A mutated protein in order to ascertain whether these two GHSs could be candidates for the development of new drugs for the treatment of ALS. The gene discussed is SOD1; the disease is neuroblastoma.